Immunopathobiology and therapeutic targets related to cytokines in liver diseases
Year: 2020
Type: review
Abstract: Chronic liver injury with any etiology can progress to fibrosis and the end-stage diseases cirrhosis and hepatocellular carcinoma. The progression of liver disease is controlled by a variety of factors, including liver injury, inflammatory cells, inflammatory mediators, cytokines, and the gut microbiome. In the current review, we discuss recent data on a large number of cytokines that play important roles in regulating liver injury, inflammation, fibrosis, and regeneration, with a focus on interferons and T helper (Th) 1, Th2, Th9, Th17, interleukin (IL)-1 family, IL-6 family, and IL-20 family cytokines. Hepatocytes can also produce certain cytokines (such as IL-7, IL-11, and IL-33), and the functions of these cytokines in the liver are briefly summarized. Several cytokines have great therapeutic potential, and some are currently being tested as therapeutic targets in clinical trials for the treatment of liver diseases, which are also described.
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,480
Awards: Innate immune signaling in alcoholic liver disease, Biomarkers of Disease in Alcoholic Hepatitis, Fibrocytes regulate liver fibrosis, Novel IL-23 inhibitor for the treatment of alcohol associated liver disease, The Role of IL-17 in Alcoholic Liver Disease and Cancer, Epigenetic Regulation of Alcoholic Liver Fibrosis, The Role of Fibrocytes in Liver Fibrosis, Alcohol and Monocyte Signaling, The role of IL-17 signaling in alcohol-induced HCC, The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis, Innate immune signaling in alcoholic liver disease, Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH
OpenAlex ID: W3103076033
